Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Liabilities and Shareholders Equity (2020 - 2025)

Alignment Healthcare's Liabilities and Shareholders Equity history spans 6 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 36.28% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $4.1 billion, up 43.92%, while the annual FY2025 figure was $1.1 billion, 36.28% up from the prior year.
  • Liabilities and Shareholders Equity reached $1.1 billion in Q4 2025 per ALHC's latest filing, down from $1.1 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.1 billion in Q3 2025 to a low of $591.9 million in Q4 2023.
  • Average Liabilities and Shareholders Equity over 5 years is $757.9 million, with a median of $704.3 million recorded in 2024.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 86.38% in 2021, then dropped 16.87% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $630.9 million in 2021, then grew by 0.47% to $633.9 million in 2022, then dropped by 6.62% to $591.9 million in 2023, then skyrocketed by 32.13% to $782.1 million in 2024, then soared by 36.28% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ALHC's Liabilities and Shareholders Equity are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.0 billion (Q2 2025).